| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |